 |
Diethylenetriaminepentaacetic acid (DTPA) |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination |
| USA Market Approval | USA |
| USA Designation Date | 2004-04-28 00:00:00 |
| Sponsor | Hameln Pharmaceuticals gmbh;Langes Feld 13;Hameln |
